Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuation versus temporary interruption of P2Y12 antiplatelet therapy for colonoscopy with polypectomy
ACTRN12616000895482Phase 4Recruiting
- Sponsor
- Alfred Health
- Start
- Aug 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of clopidogrel, prasugrel, ticagrelor and aspirin in colon adenoma (2 arms), sponsored by Alfred Health. Primary endpoint: Composite primary bleeding endpoint. Started Aug 2016; status: recruiting.
02
Drugs
clopidogrelprasugrelticagreloraspirin
03
Conditions
colon adenoma
Beyond the preview
Go deeper on ACTRN12616000895482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616000895482.